Literature DB >> 23769164

Influenza vaccination and reduction in risk of ischemic heart disease among chronic obstructive pulmonary elderly.

Chen-Ling Huang1, Phung Anh Nguyen, Pih-lian Kuo, Usman Iqbal, Yi-Hsin Elsa Hsu, Wen-Shan Jian.   

Abstract

COPD estimates the third leading cause of death by 2020. To reduce its complications becomes an important issue. The purpose of this study is to investigate the influenza vaccine effect for IHD occurrence with secondary to COPD. We used 11 years Taiwan National Health Insurance cohort research database and analyzed the relationships between vaccination and incident of IHD for COPD patients stratified by age. Total 29,178 COPD patients, 703 patients got vaccination out of 1464 who have developed IHD and 6010 patients vaccinated out of 27,714 that did not developed IHD. Major findings we observed: vaccination was associated with a reduced risk of IHD (OR, 0.746; 95% CI, 0.595-0.937) in elderly COPD patients. Influenza vaccination was associated with a reduced risk for IHD only in elderly COPD patients. Moreover, COPD patients with IHD had higher vaccination rate than without IHD.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  COPD (chronic obstructive pulmonary disease); Cohort research database; IHD (ischemic heart disease); Influenza vaccine; Vaccination

Mesh:

Substances:

Year:  2013        PMID: 23769164     DOI: 10.1016/j.cmpb.2013.05.006

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  9 in total

Review 1.  Optimizing bronchodilation in the prevention of COPD exacerbations.

Authors:  Marc Miravitlles; Antonio Anzueto; José R Jardim
Journal:  Respir Res       Date:  2017-06-20

2.  Essentials in the Comprehensive Management of Chronic Respiratory Diseases: Airway Clearance and Vaccination.

Authors:  Aslı Görek Dilektaşlı; Zeynep Pınar Önen
Journal:  Turk Thorac J       Date:  2018-07-01

Review 3.  Update on management of stable chronic obstructive pulmonary disease.

Authors:  Ritwick Agrawal; Shahram Moghtader; Uma Ayyala; Venkata Bandi; Amir Sharafkhaneh
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

4.  Trends in Influenza Vaccination Rates in Participants With Airflow Limitation: The Korea National Health and Nutrition Examination Survey 2007-2018.

Authors:  Hyun Lee; Hayoung Choi; Yong Suk Jo
Journal:  Front Med (Lausanne)       Date:  2022-05-03

5.  Is long-term use of benzodiazepine a risk for cancer?

Authors:  Usman Iqbal; Phung-Anh Nguyen; Shabbir Syed-Abdul; Hsuan-Chia Yang; Chih-Wei Huang; Wen-Shan Jian; Min-Huei Hsu; Yun Yen; Yu-Chuan Jack Li
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

Review 6.  Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality.

Authors:  Yangyang Cheng; Xinxi Cao; Zhi Cao; Chenjie Xu; Li Sun; Ying Gao; Yuan Wang; Shu Li; Cunjin Wu; Xin Li; Yaogang Wang; Sean X Leng
Journal:  Ageing Res Rev       Date:  2020-07-16       Impact factor: 10.895

7.  The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context.

Authors:  Francesco Blasi; Paolo Bonanni; Fulvio Braido; Giovanni Gabutti; Federico Marchetti; Stefano Centanni
Journal:  Hum Vaccin Immunother       Date:  2019-09-06       Impact factor: 3.452

Review 8.  Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Marcos I Restrepo; Oriol Sibila; Antonio Anzueto
Journal:  Tuberc Respir Dis (Seoul)       Date:  2018-07

Review 9.  Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.

Authors:  Radha Gopal; Michael A Marinelli; John F Alcorn
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.